DoW Neurofibromatosis Exploration-Hypothesis Development Award RFP

Description: The FY26 DoW Neurofibromatosis Exploration-Hypothesis Development Award (EHDA) is a discretionary grant opportunity that funds initial, high-risk/high-gain exploratory research in neurofibromatosis, supporting projects with a well-formulated, testable hypothesis. Awards are for up to two years with a total cost cap per award and encourage multidisciplinary collaborations across DoD, VA, academia and industry. The opportunity was posted June 25, 2026 and applications are due September 22, 2026 via the grants.gov/eBRAP application process.